HCR 551 Module 3 CAPA Writing Assignment Example

Course	HCR 551 Clinical Research Monitoring
Module	Module 3
Paper type	CAPA plan
Length	About 694 words, 5 pages
Format	APA 7 student paper
School	Arizona State University
Program	MS in Clinical Research Management
Updated	October 2026

Free sample paper for HCR 551 Module 3

CAPA Plan: Study Drug Given Despite Out-of-Range Laboratory Values at Site 014

Student Name

MS in Clinical Research Management, Arizona State University

HCR 551: Clinical Research Monitoring

Instructor Name

Month Day, Year

What this page is doingThe title follows the form of a CAPA record, naming the finding and the site.

CAPA Plan: Study Drug Given Despite Out-of-Range Laboratory Values at Site 014

1. Problem Statement

During the monitoring visit of September 15, 2026, at Site 014 of Protocol ONC-307, source data verification found that three of 18 enrolled participants received study drug on Day 1 of a treatment cycle when their absolute neutrophil count (ANC) was below 1,500 per microliter, the protocol's minimum for dosing. Each event occurred between July and August 2026. The protocol requires dose delay until ANC recovers, and investigators are obliged to follow the investigational plan (21 C.F.R. § 312.60).

What this page is doingA problem statement that gives the number, the rule, the dates and the source of discovery lets a reader judge scope without reading further.

2. Impact Assessment

Participant safety: dosing below threshold increases the risk of febrile neutropenia. The medical monitor reviewed all three participants; one had a grade 2 infection treated as an outpatient, and none required hospitalization. Data integrity: the dose intensity data for three participants deviate from protocol and must be flagged. Reporting: the deviations were classified as important protocol deviations, reported to the sponsor within one business day and to the IRB according to its reporting policy.

3. Immediate Correction

On September 16, the principal investigator confirmed that all current participants' next doses would require a documented ANC check. The site was retrained the same day on the dosing criteria, and the sponsor issued a reminder to all sites.

4. Root Cause Analysis

A fishbone review with the site team, following the course workbook's root cause method (Shah & Pfeiffer, 2021), grouped possible causes under people, process, tools and environment.

Five whys on the main process cause:

1. Why was drug given below threshold? The infusion order had been released before the morning laboratory result was reviewed.

2. Why was it released early? Orders for Day 1 are signed the evening before to secure infusion chair time.

3. Why does chair time drive the order? The infusion center requires orders 12 hours in advance.

4. Why was the laboratory check not built into the order? The research order set was copied from a standard-of-care regimen that uses a different threshold.

5. Why was that not caught? The site's order set review checklist does not compare research order sets with protocol dosing criteria.

Root cause: research order sets are not verified against protocol dosing rules, and the scheduling process separates the dosing decision from the laboratory result.

Category	Possible cause	Finding
People	New research nurse unfamiliar with protocol	Two of three events occurred on her shifts
Process	Laboratory results reviewed after drug was ordered	Confirmed: orders placed the evening before Day 1
Tools	Electronic order set has no dosing threshold check	Confirmed
Environment	Infusion center scheduling pressure	Contributing; same-day infusion slots fill early

5. Corrective and Preventive Actions

Action	Type	Owner	Due date	Evidence
Add an ANC hard stop at 1,500 per microliter to the ONC-307 order set	Corrective	Site pharmacist and principal investigator	September 30, 2026	Screenshot of revised order set
Hold Day 1 orders as pending until the morning ANC is reviewed and documented	Corrective	Research nurse manager	September 30, 2026	Revised site procedure
Add protocol dosing criteria comparison to the research order set checklist for all studies	Preventive	Research pharmacy	October 31, 2026	Updated checklist
Protocol-specific dosing training for all nurses before first patient contact	Preventive	Study coordinator	October 15, 2026	Training log
Agree with infusion center on provisional chair holds for research patients	Preventive	Clinic operations	October 31, 2026	Written agreement

6. Effectiveness Check

The CRA will review 100% of Day 1 dosing records at Site 014 for the next three cycles of every participant and confirm a documented ANC before each dose. Success means no dosing below threshold. Central monitoring will also flag any dose recorded on a day without an ANC entry. The CAPA will be closed only after three months without recurrence and verification that the order set change is in place for other studies using the same regimen (U.S. Food and Drug Administration, 2025).

7. Conclusion

The finding looked like individual error, but the root cause was a process that placed dosing decisions before laboratory review and an order set never checked against the protocol. Fixing those two system features, and checking that the fix works, addresses the cause rather than the symptom.

References

General responsibilities of investigators, 21 C.F.R. § 312.60 (2025).

Shah, K., & Pfeiffer, J. P. (2021). Clinical research management: Complementary materials. LAD Custom Publishing.

U.S. Food and Drug Administration. (2025). E6(R3) good clinical practice (GCP) [Guidance for industry]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r3-good-clinical-practice-gcp

HCR 551 Module 3 instructions, in plain terms

The CAPA Writing Assignment, worth 75 points, falls in Week 3 of HCR 551, the week on CAPAs, monitoring tools and monitoring documentation. Developing an effective corrective and preventive action plan is one of the course's stated learning outcomes, and the full instructions and any scenario sit in Canvas. A CAPA records a problem precisely, assesses its impact, documents the immediate correction, finds the root cause and sets actions that fix the problem and stop it recurring, with owners, dates, evidence and a check that the actions worked. The course workbook, Shah and Pfeiffer's Clinical Research Management: Complementary Materials, covers CAPA development alongside source data verification and monitoring visits. Treat the CAPA as a document a sponsor or auditor would read, because that is how CAPAs are used in practice.

Inside the HCR 551 Module 3 example

The sample is laid out as a numbered CAPA record. The problem statement gives the count, the rule broken, the dates and how the finding was discovered. An impact assessment covers safety, data and reporting, and a short section records the immediate correction. The root cause analysis uses two tools: a fishbone table that tests causes in four categories and a five-whys chain on the main process cause, ending in a stated root cause. A table of five actions marks each as corrective or preventive with an owner, a date and evidence. The effectiveness check sets a measurable success criterion and a closure rule. The record is short enough to scan in a minute, which is how auditors read CAPAs.

Reading the HCR 551 Module 3 grading rubric

Seventy-five points are available for the CAPA. A strong plan states the problem specifically, assesses impact on safety and data, separates the immediate correction from corrective and preventive actions, reaches a root cause that is systemic, assigns owners, dates and evidence and defines a measurable effectiveness check with a closure criterion. Points are lost when the root cause is "human error" or "staff not trained," when actions are vague, when correction and prevention are confused and when nothing would reveal whether the fixes held. Readers value CAPAs where each action traces back to a stated cause, since that is how auditors test whether a CAPA is real.

HCR 551 Module 3 help from the desk

Write the problem statement with numbers, the rule and the dates first. Assess safety before data. Use at least one structured root cause tool. Do not stop at training; ask why the system allowed the error. Give every action an owner, a due date and evidence of completion. Define what success looks like and when the CAPA can close. Write it as a document someone else will audit. If your scenario is thin on detail, the desk can help you decide which reasonable assumptions to state. Avoid closing the CAPA as soon as actions are complete; closure depends on evidence that the problem has not recurred. Keep the language factual and free of blame, since site staff will read it.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official Arizona State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.

More HCR 551 and MS in Clinical Research Management sample papers

HCR 551 Module 3 questions, answered

Where can I find a free HCR 551 Module 3 sample paper?

This page has a full HCR 551 CAPA Writing Assignment sample for dosing despite out-of-range laboratory values.

What are the parts of a CAPA plan?

Problem statement, impact assessment, immediate correction, root cause analysis, corrective and preventive actions with owners and dates and an effectiveness check.

What is the difference between correction, corrective action and preventive action?

Correction fixes the immediate problem, corrective action removes its cause and preventive action stops similar problems elsewhere.

Why is human error not a good root cause?

It does not explain why the system allowed the error, so fixing it rarely prevents recurrence.

Which workbook does HCR 551 use?

Shah and Pfeiffer's Clinical Research Management: Complementary Materials.